Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 PPARG [2] Transcriptional misregulation in cancer, Thyroid cancer D00596 Rosiglitazone [5] 46, 75, 97, 222, 265
2 PPARG [2] Transcriptional misregulation in cancer, Thyroid cancer D00945 Pioglitazone [17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
3 PPARG [2] Transcriptional misregulation in cancer, Thyroid cancer D08378 Pioglitazone [17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
4 PPARG [2] Transcriptional misregulation in cancer, Thyroid cancer D08491 Rosiglitazone [5] 46, 75, 97, 222, 265
5 PPARG [2] Transcriptional misregulation in cancer, Thyroid cancer D11256 Seladelpar [2] 93, 94
6 PPARG [2] Transcriptional misregulation in cancer, Thyroid cancer D11603 Leriglitazone [1] 20
7 MAP2K1 [7] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D09666 Selumetinib [1] 34
8 MAP2K1 [7] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10175 Trametinib [4] 2, 34, 279, 280
9 MAP2K1 [7] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10405 Cobimetinib [1] 280
10 MAP2K1 [7] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10604 Binimetinib [1] 34
11 MAP2K2 [6] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D09666 Selumetinib [1] 34
12 MAP2K2 [6] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10175 Trametinib [4] 2, 34, 279, 280
13 MAP2K2 [6] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10405 Cobimetinib [1] 280
14 MAP2K2 [6] Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10604 Binimetinib [1] 34
15 RET [1] Thyroid cancer D06272 Sorafenib [2] 34, 86
16 RET [1] Thyroid cancer D06402 Sunitinib [2] 28, 34
17 RET [1] Thyroid cancer D08524 Sorafenib [2] 34, 86
18 RET [1] Thyroid cancer D08552 Sunitinib [2] 28, 34
19 RXRA [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
20 RXRA [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
21 RXRA [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
22 RXRB [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
23 RXRB [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
24 RXRB [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
25 RXRG [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
26 RXRG [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
27 RXRG [3] Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
28 BRAF [2] Vascular smooth muscle contraction, Thyroid cancer D06272 Sorafenib [2] 34, 86
29 BRAF [2] Vascular smooth muscle contraction, Thyroid cancer D08524 Sorafenib [2] 34, 86
30 BRAF [2] Vascular smooth muscle contraction, Thyroid cancer D10064 Dabrafenib [1] 34